The PBMCs were isolated by a density gradient with Hystopaque reagent (Sigma-Aldrich, St. Louis, MO, USA) or Lymphoprep™ (Alere Technologies AS, Oslo, Norway). The PBMCs, obtained from healthy donors, were treated with two concentrations of calcitriol (1x10-8M and 5x10-10M) or ethanol at 1% (EtOH), as vehicle control (Sigma-Aldrich) for 24 hours at 37°C and 5% CO2. The PBMCs from HESNs were treated with only one concentration of calcitriol at 1x10-9M due to sample limitation. PBMCs of all recruited individuals were stimulated with phytohemagglutinin (PHA) (Sigma-Aldrich) (8ug/ml) and IL-2 (50 IU/mL) (Sigma) for 48 hours, before HIV-1 infection, maintaining supplementation with calcitriol.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.